The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
A genetically humanized mouse model for hepatitis C virus infection
Open accessAbstract
Hepatitis C virus (HCV) remains a major medical problem. Antiviral treatment is only partially effective and a vaccine does not exist. Development of more effective therapies has been hampered by the lack of a suitable small animal model. Although xenotransplantation of immunodeficient mice with human hepatocytes has shown promise, these models are subject to important challenges. Building on the previous observation that CD81 and occludin comprise the minimal human factors required to render mouse cells permissive to HCV entry in vitro, we attempted murine humanization via a genetic approach. Here we show that expression of two human genes is sufficient to allow HCV infection of fully immunocompetent inbred mice. We establish a precedent for applying mouse genetics to dissect viral entry and validate the role of scavenger receptor type B class I for HCV uptake. We demonstrate that HCV can be blocked by passive immunization, as well as showing that a recombinant vaccinia virus vector induces humoral immunity and confers partial protection against heterologous challenge. This system recapitulates a portion of the HCV life cycle in an immunocompetent rodent for the first time, opening opportunities for studying viral pathogenesis and immunity and comprising an effective platform for testing HCV entry inhibitors in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Self-citationComplete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238
Self-citationBinding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wölk, B., Hatziioannou, T., McKeating, J. A., Bieniasz, P. D., & Rice, C. M. (2007) · Nature · doi:10.1038/nature05654 · Cited by 1,232
Self-citationThe human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Ploss, A., Evans, M. J., Gaysinskaya, V. A., Panis, M., You, H., de Jong, Y. P., & Rice, C. M. (2009) · Nature · doi:10.1038/nature07684 · Cited by 941
Self-citationHepatitis C virus replication in mice with chimeric human livers
Mercer, D. F., Schiller, D. E., Elliott, J. F., Douglas, D. N., Hao, C., Rinfret, A., Addison, W. R., Fischer, K. P., Churchill, T. A., Lakey, J. R. T., et al. (2001) · Nature Medicine · doi:10.1038/90968 · Cited by 901
Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 860
Analysis of a Successful Immune Response against Hepatitis C Virus
Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P., & Walker, C. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80044-8 · Cited by 814
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Law, M., Maruyama, T., Lewis, J., Giang, E., Tarr, A. W., Stamataki, Z., Gastaminza, P., Chisari, F. V., Jones, I. M., Fox, R. I., et al. (2008) · Nature Medicine · doi:10.1038/nm1698 · Cited by 591
Self-citationFlint, M., Maidens, C., Loomis-Price, L. D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S., & McKeating, J. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6235-6244.1999 · Cited by 469
Morphological and biochemical characterization of a human liver in a uPA‐SCID mouse chimera†‡
Meuleman, P., Libbrecht, L., De Vos, R., de Hemptinne, B., Gevaert, K., Vandekerckhove, J., Roskams, T., & Leroux‐Roels, G. (2005) · Hepatology · doi:10.1002/hep.20657 · Cited by 374
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
Bissig, K.-D., Wieland, S. F., Tran, P., Isogawa, M., Le, T. T., Chisari, F. V., & Verma, I. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40094 · Cited by 356
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
Jones, C. T., Catanese, M. T., Law, L. M. J., Khetani, S. R., Syder, A. J., Ploss, A., Oh, T. S., Schoggins, J. W., MacDonald, M. R., Bhatia, S. N., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1604 · Cited by 249
Self-citationCell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
Marukian, S., Jones, C. T., Andrus, L., Evans, M. J., Ritola, K. D., Charles, E. D., Rice, C. M., & Dustin, L. B. (2008) · Hepatology · doi:10.1002/hep.22550 · Cited by 240
Self-citationHigginbottom, A., Quinn, E. R., Kuo, C.-C., Flint, M., Wilson, L. H., Bianchi, E., Nicosia, A., Monk, P. N., McKeating, J. A., & Levy, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3642-3649.2000 · Cited by 225
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
Ploss, A., Khetani, S. R., Jones, C. T., Syder, A. J., Trehan, K., Gaysinskaya, V. A., Mu, K., Ritola, K., Rice, C. M., & Bhatia, S. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915130107 · Cited by 211
Self-citationVisualizing Hepatitis C Virus Infections in Human Liver by Two-Photon Microscopy
Liang, Y., Shilagard, T., Xiao, S., Snyder, N., Lau, D., Cicalese, L., Weiss, H., Vargas, G., & Lemon, S. M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.050 · Cited by 171
Catanese, M. T., Graziani, R., von Hahn, T., Moreau, M., Huby, T., Paonessa, G., Santini, C., Luzzago, A., Rice, C. M., Cortese, R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00193-07 · Cited by 160
Self-citationSafran, M., Kim, W. Y., Kung, A. L., Horner, J. W., Depinho, R. A., & Kaelin, W. G. (2003) · Molecular Imaging · doi:10.1162/153535003322750637 · Cited by 134
Replication of a hepatitis C virus replicon clone in mouse cells.
Uprichard, S. L., Chung, J., Chisari, F. V., & Wakita, T. (2006) · Virology Journal · doi:10.1186/1743-422x-3-89 · Cited by 98
Chang, K.-S., Cai, Z., Zhang, C., Sen, G. C., Williams, B. R. G., & Luo, G. G. (2006) · Journal of Virology · doi:10.1128/jvi.00586-06 · Cited by 92
Determinants of Hepatitis C Translational Initiation in Vitro, in Cultured Cells and Mice
McCaffrey, A. P., Ohashi, K., Meuse, L. A., Shen, S., Lancaster, A. M., Lukavsky, P. J., Sarnow, P., & Kay, M. A. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0600 · Cited by 91
Lin, L., Noyce, R. S., Pham, T. N. Q., Wilson, J. A., Sisson, G. R., Michalak, T. I., Mossman, K. L., & Richardson, C. D. (2010) · Journal of Virology · doi:10.1128/jvi.00559-10 · Cited by 65
An Flp indicator mouse expressing alkaline phosphatase from the ROSA26 locus
Awatramani, R. B., Soriano, P. M., Jia, J., & Dymecki, S. M. (2001) · Nature Genetics · doi:10.1038/ng1101-257 · Cited by 61
Selby, M., Erickson, A. L., Dong, C., Cooper, S., Parham, P., Houghton, M., & Walker, C. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.669 · Cited by 57
New horizons for studying human hepatotropic infections
de Jong, Y. P., Rice, C. M., & Ploß, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42338 · Cited by 57
Self-citationStoller, J. Z., Degenhardt, K. R., Huang, L. F., Zhou, D. D., Lu, M. M., & Epstein, J. A. (2008) · genesis · doi:10.1002/dvg.20384 · Cited by 42
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Prediction and prevention of the next pandemic zoonosis.
Morse, S. S., Mazet, J. A., Woolhouse, M., Parrish, C. R., Carroll, D., Karesh, W. B., Zambrana-Torrelio, C., Lipkin, W. I., & Daszak, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61684-5 · Cited by 1,070
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554
Self-citationThe cell biology of receptor-mediated virus entry
Grove, J., & Marsh, M. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201108131 · Cited by 510
Broadly Neutralizing Antiviral Antibodies
Corti, D., & Lanzavecchia, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095916 · Cited by 475
Metadata
- Authors
- Dorner, M., Horwitz, J. A., Robbins, J. B., Barry, W. T., Feng, Q., Mu, K., Jones, C. T., Schoggins, J. W., Catanese, M. T., Burton, D. R., Law, M., Rice, C. M., & Ploss, A.
- Venue
- Nature
- Published
- 2011-06-08
- Volume
- 474
- Issue
- 7350
- Pages
- 208-211
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1986551392
- Cited by
- 378
- References
- 28
- FWCI
- 36.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.